SciSight Ecosystem
WoS ESCI Q3Scopus Q3SCImago #12,346CAS 4区Hybrid

Drug Research

Country: Germany•WoS SCIE Quartile: Q3•Scopus SJR: 0.479•SCImago Rank: #12,346•Identifier (ISSN):2194-9379(Print)/2194-9387(Online)•Articles / Year: 50•Estimated Publication Fee (APC): $2,805 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q3
2.4
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
76

76 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
50articles/year
1.52% Gold OA•78.13% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.1)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.7)
🔵 Computed
20231.50đ
WoS Q3(IF: 2.2)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. Publishing twelve times a year, Drug Research includes original research articles as well as reviews, commentaries and short communications in the following areas: analytics applied to clinical trials chemistry and biochemistry clinical and experimental pharmacology drug interactions efficacy testing pharmacodynamics pharmacokinetics teratology toxicology.

Topics Covered (Recognized by AI)
MedicineBiologyChemistryInternal MedicineBiochemistryPharmacologyGeneticsOrganic ChemistryEndocrinologyPsychologyPhysicsPathologyBioinformaticsPsychiatry
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,346Scopus Q3SCImago Profile
Scopus Coverage:1972, 2013-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.479

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
76

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.28

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,805 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations431
3-Year Documents169
Citable Documents169

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3
Medicine (miscellaneous)Q3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Thieme
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRESCI
215/356Q3
PHARMACOLOGY & PHARMACY
JCIESCI
275/356Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—2215
20252.145180
20241.758195
20232.257358
2022—75515
2021—75497
2020—1211,319
2019—79637
2018—1301,954
2017—1542,260
2016—1201,616
2015—86739
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Drug Research

WoS Q3
12232023202420252.10
Annual Impact Factor Metric
2025:2.1

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 43d19f9e-cf19-4a8f-8a90-c675e6e4b1d0
Database Updated: 2026-09-28